Your browser doesn't support javascript.
loading
Evaluation of TAK-264, an Antibody-Drug Conjugate in Pancreatic Cancer Cell Lines and Patient-Derived Xenograft Models.
Schreiber, Anna R; Nguyen, Anna; Bagby, Stacey M; Arcaroli, John J; Yacob, Betelehem W; Quackenbush, Kevin; Guy, Joe L; Crowell, Thomas; Stringer, Bradley; Danaee, Hadi; Kalebic, Thea; Messersmith, Wells A; Pitts, Todd M.
Affiliation
  • Schreiber AR; Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, CO, USA.
  • Nguyen A; Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, CO, USA.
  • Bagby SM; Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, CO, USA.
  • Arcaroli JJ; Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, CO, USA.
  • Yacob BW; University of Colorado Cancer Center, Aurora, CO, USA.
  • Quackenbush K; Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, CO, USA.
  • Guy JL; Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, CO, USA.
  • Crowell T; Univeristy of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.
  • Stringer B; Takeda, Cambridge, MA, USA.
  • Danaee H; Takeda, Cambridge, MA, USA.
  • Kalebic T; Takeda, Cambridge, MA, USA.
  • Messersmith WA; Takeda, Cambridge, MA, USA.
  • Pitts TM; Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, CO, USA.
Clin Cancer Drugs ; 5(1): 42-49, 2018.
Article de En | MEDLINE | ID: mdl-30631747

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: Clin Cancer Drugs Année: 2018 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: Clin Cancer Drugs Année: 2018 Type de document: Article Pays d'affiliation: États-Unis d'Amérique